PRAXIS PRECISION MEDICINES, INC. (PRAX)
Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies
Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies
Kaiser Aluminum Corporation Publishes 2025 Sustainability Report
ITT Announces Appointment of Bertrand Loy and Kevin Wheeler to Board of Directors
DePuy Synthes Appoints Christina Zamarro as Chief Financial Officer
Mama’s Creations. Announces Proposed Public Offering of Common Stock
Rosen Law Firm Urges Peabody Energy Corporation (NYSE: BTU) Stockholders to Contact the Firm for Information About Their Rights
TMD Energy Limited Announces Financial Results for the Six Months Ended December 31, 2025
First Reliance Bancshares Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of First Reliance Bancshares, Inc. - FSRL
Bio-Techne Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Bio-Techne Corporation - TECH
FS KKR Capital Corp. Closes $150 Million Convertible Preferred Stock Issuance in Connection with Strategic Value Enhancement Actions